Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials
EuroIntervention 2011;7:985-994 publish online ahead of print November 2011. DOI: 10.4244/EIJV7I8A155
Eliano Pio Navarese1*, MD, FEAPCI; Jacek Kubica1, MD, PhD; Fausto Castriota2, MD, FESC; C. Michael Gibson3, MS, MD, FACC; Giuseppe De Luca4, MD, PhD; Antonino Buffon5, MD; Leonardo Bolognese6, MD; Massimo Margheri7, MD; Felicita Andreotti5, MD, PhD, FESC; Carlo Di Mario8, MD, FESC; Stefano De Servi9, MD, FESC
1. Department of Cardiology and Internal Medicine, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland; 2. GVM Care and Research, Interventional Cardio-Angiology Unit, Cotignola, Italy; 3. Cardiovascular
Aims: Drug-eluting stents (DES) are a major advance in interventional cardiology; however concerns have been raised regarding their long-term sa
